Crossmark

Exosomal miR-20a-5p derived from cisplatin-resistant osteosarcoma cells promotes chemoresistance via Inhibition of ferroptosis through targeting RUNX3

Crossref DOI link: https://doi.org/10.1038/s41598-025-29305-7

Published Online: 2025-11-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Peng

Deng, Luyue

Chen, Kai

Ding, Wenli

Niu, Xiaoying

Tian, Wen
Funding

Funding for this research was provided by:

Natural Science Foundation of Henan Province (252300420125)

National Natural Science Foundation of China (82303914)
License Information

Text and Data Mining valid from 2025-11-27

Version of Record valid from 2025-12-30
More Information

Article History

Received: 11 July 2025

Accepted: 17 November 2025

First Online: 27 November 2025

Declarations

:

: The authors declare no competing interests.

: This study was approved by the Ethics Committee of Henan Cancer Hospital (2022-200-001).

Document is current

Any future updates will be listed below